Hjem › Atrieflimmer › Alabama
Atrieflimmer kliniske forsøg i Alabama
11 studier for Atrieflimmer søger deltagere på steder i Alabama.
Byer i Alabama
Officiel studietekst (engelsk)
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Advanced Cardiovascular, Alexander City
- SEC Clinical Research, Dothan
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07626411Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- SEC Clinical Research, Dothan
- Eastern Shore Research Institute, Fairhope
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07175428A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
- Grandview Medical Center, Birmingham
Rekrutterer
Alder 18 til 80 · Alle køn · Opdateret 25. sep. 2026 · NCT07527299Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
- University of Alabama at Birmingham, Birmingham
- Grandview Medical Center, Birmingham
- Cardiology Associates of Mobile, Mobile
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT04088071Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- SEC Clinical Research, Dothan
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT07430956Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
- University of Alabama at Birmingham (UAB) Hospital, Birmingham
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 31. jul. 2026 · NCT07298473Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
- Grandview, Birmingham
Rekrutterer
Alder 18 til 80 · Alle køn · Opdateret 15. jul. 2026 · NCT06784466Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Anthos Investigative Site 1040, Birmingham
- Anthos Investigational site 9939, Birmingham
- Anthos Investigative Site 9947, Birmingham
- og 1 flere
RekruttererFase 3
Alder 65 og opefter · Alle køn · Opdateret 13. jul. 2026 · NCT05712200Tracking Results of Ablations to Combat AF Registry Generation 2
- Huntsville Hospital, Huntsville
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 29. jun. 2026 · NCT05111015Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- University of Alabama Hospital, Birmingham
- University of South Alabama University Hospital, Mobile
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 8. maj 2026 · NCT03907046The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
- Arrhythmia Institute at Grandview, Birmingham
- Mobile Cardiology Associates, Mobile
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 31. okt. 2025 · NCT06324201Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.